blindness with tirzepatide as Adjunct to Insulin in Adults Type 1 Diabetes and Overweight or Obesity: A Systematic Review of Randomized and Real‐World Evidence Tirzepatide monotherapy in Chinese patients

Some users have reported experiencing more vivid or unusual dreams while on the medication, although this is not officially listed as a side effect

The present findings are supported by the results of the SECRET trial, which showed that non-pharmacologic body weight reduction achieved through caloric restriction improved exercise capacity in patients with the obesity phenotype of HFpEF 15

It was a bad fall

Should side effects persist or intensify, seek medical advice to adjust your treatment plan accordingly

Tirzepatide reduced the number of breathing interruptions by about 2529 events per hour, compared with about 5 per hour with placebo